Picture of Arix Bioscience logo

ARIX Arix Bioscience News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapMomentum Trap

REG-Arix Bioscience PLC Holding(s) in Company

============

   Arix Bioscience PLC (ARIX)
   Holding(s) in Company

   04-Jan-2024 / 17:30 GMT/BST

   ═══════════════════════════════════════════════════════════════════════════

   TR-1: Standard form for notification of major holdings

    

   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to
   the FCA in Microsoft Word format if possible)i
                                                                              
   1a. Identity of the issuer or the                ARIX Bioscience PLC
   underlying issuer of existing shares to
   which voting rights are attachedii:                        
   1b. Please indicate if the issuer is a non-UK issuer (please mark with an
   “X” if appropriate)
   Non-UK issuer                                                           
   2. Reason for the notification (please mark the appropriate box or boxes
   with an “X”)
   An acquisition or disposal of voting rights                             
   An acquisition or disposal of financial instruments                    X
   An event changing the breakdown of voting rights                        
   Other (please specify)iii:                                              
   3. Details of person subject to the notification obligationiv
   Name                                      Weiss Asset Management LP
   City and country of registered office (if Wilmington, Delaware, USA
   applicable)
   4. Full name of shareholder(s) (if different from 3.)v
                                             Brookdale International Partners,
   Name                                      L.P., Brookdale Global
                                             Opportunity Fund
                                             Brookdale International Partners,
                                             L.P.: Albany, NY, USA
   City and country of registered office (if
   applicable)                               Brookdale Global Opportunity
                                             Fund: Grand Cayman, Cayman
                                             Islands
   5. Date on which the threshold was        January-2-2024
   crossed or reachedvi:
   6. Date on which issuer notified          January-4-2024
   (DD/MM/YYYY):
   7. Total positions of person(s) subject to the notification obligation
                       % of voting     % of voting
                         rights      rights through   Total of Total number of
                       attached to      financial     both in  voting rights
                      shares (total    instruments    % (8.A + of issuervii
                        of 8. A)    (total of 8.B 1 +   8.B)
                                         8.B 2)
   Resulting
   situation on the
   date on which      0.00          5.19              5.19     129,389,508
   threshold was
   crossed or reached
   Position of
   previous                                               
   notification (if                                             
                           N/A             N/A          N/A
   applicable)
                                                                        

    

   8. Notified details of the resulting situation on the date on which the
   threshold was crossed or reachedviii
   A: Voting rights attached to shares
   Class/type   Number of voting rightsix          % of voting rights
   of                 Direct          Indirect         Direct       Indirect
   shares
                    (Art 9 of        (Art 10 of      (Art 9 of     (Art 10 of
   ISIN code        Directive         Directive      Directive     Directive
   (if             2004/109/EC)     2004/109/EC)    2004/109/EC)  2004/109/EC)
   possible)         (DTR5.1)        (DTR5.2.1)       (DTR5.1)     (DTR5.2.1)
                                                                   
                                                                   
                                                                   
   SUBTOTAL 8.                                                   
   A
    

    
   B 1: Financial Instruments according to Art. 13(1)(a) of Directive
   2004/109/EC (DTR5.3.1.1 (a))
                                             Number of voting
   Type of                 Exercise/         rights that may be
   financial    Expiration Conversion        acquired if the      % of voting
   instrument   datex      Periodxi          instrument is        rights

                                             exercised/converted.
                                                                   
                                                                   
                                                                   
                           SUBTOTAL 8. B 1                         
    

    
   B 2: Financial Instruments with similar economic effect according to Art.
   13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
   Type of                 Exercise/    Physical or     Number of
   financial  Expiration   Conversion   cash            voting    % of voting
   instrument datex        Period xi                    rights    rights
                                        settlementxii
   CFD        N/A          N/A          Cash Settlement 6,725,000 5.19
                                                                   
                                                                   
                                        SUBTOTAL 8.B.2  6,725,000 5.19
    
                                                                   

    

   9. Information in relation to the person subject to the notification
   obligation (please mark the

   applicable box with an “X”)
   Person subject to the notification obligation is not controlled by
   any natural person or legal entity and does not control any other       
   undertaking(s) holding directly or indirectly an interest in the
   (underlying) issuerxiii
   Full chain of controlled undertakings through which the voting
   rights and/or the
   financial instruments are effectively held starting with the           x
   ultimate controlling natural person or legal entityxiv (please add
   additional rows as necessary)
                        % of voting     % of voting rights   Total of both if
                        rights if it     through financial    it equals or is
         Namexv         equals or is     instruments if it    higher than the
                      higher than the   equals or is higher     notifiable
                         notifiable     than the notifiable      threshold
                         threshold           threshold
   Weiss Asset                                                
   Management LP
   Brookdale
   International      0.00             2.90                  2.90
   Partners, L.P.
                                                              
   Weiss Asset                                                
   Management LP
   Brookdale Global   0.00             2.29                  2.29
   Opportunity Fund
    
   10. In case of proxy voting, please identify:
   Name of the proxy holder             
   The number and % of voting rights    
   held
   The date until which the voting      
   rights will be held
    
   11. Additional informationxvi
   Weiss Asset Management LP is the Investment Manager to Brookdale Global
   Opportunity Fund and Brookdale International Partners, L.P.
                                                                        

    

   Place of completion Boston, USA
   Date of completion  January-4-2024

    

   ═══════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ═══════════════════════════════════════════════════════════════════════════

   ISIN:           GB00BD045071
   Category Code:  HOL
   TIDM:           ARIX
   LEI Code:       213800OVT3AHQCXNIX43
   OAM Categories: 2.3. Major shareholding notifications
   Sequence No.:   295596
   EQS News ID:    1808641


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    1 fncls.ssp?fn=show_t_gif&application_id=1808641&application_name=news&site_id=refinitiv

References

   Visible links


============

Recent news on Arix Bioscience

See all news